切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Voltage-gated Potassium (KV) Channels - TYK2 - BCPCF efflux - NADPH Oxidases

10 件产品

每页
清除全部
  1. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: Nox1/Nox4双重抑制剂
      ≥39.5 mg/mL
      insoluble in H2O
  2. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    中文名: 牛磺熊去氧胆酸钠
    Target: BCPCF efflux
    Summary: 水溶性胆汁盐
      ≥26.1 mg/mL
      ≥8.42 mg/mL
  3. Cerdulatinib (PRT062070)
    B8023 Cerdulatinib (PRT062070)
    Target: JAK|Syk|TYK2
    Summary: Syk/JAK抑制剂
      ≥22.3 mg/mL
      insoluble in H2O
  4. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  5. Diphenyleneiodonium chloride
    B6326 Diphenyleneiodonium chloride
    中文名: 二苯基氯化碘盐
    Target: NADPH Oxidases|NOS|GPR3
    Summary: iNOS和eNOS抑制剂,GPR3激动剂
      ≥6.99 mg/mL
      insoluble in H2O
  6. Apocynin
    B3675 Apocynin
    中文名: 罗布麻宁,夹竹桃麻素,香兰基甲基酮
    Target: NADPH Oxidases
    Summary: 选择性NADPH氧化酶抑制剂
      ≥8.25 mg/mL
  7. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  8. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. LY2784544
    A4147 LY2784544
    Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3K
    Summary: JAK2抑制剂
      ≥23.5 mg/mL
      insoluble in H2O

10 件产品

每页